The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Antitumor activity of a phosphorothioate antisense oligodeoxynucleotide targeted against C-raf kinase
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Meyer, T., Regenass, U., Fabbro, D., Alteri, E., Röusel, J., Möller, M., Caravatti, G., & Matter, A. (1989) · International Journal of Cancer · doi:10.1002/ijc.2910430519 · Cited by 407
Self-citationRetractedCurrent protocols in molecular biology
Sargent, T. (1988) · Analytical Biochemistry · doi:10.1016/0003-2697(88)90147-9 · Cited by 7,205
ras oncogenes in human cancer: a review.
Bos, J. L. (1989) · PubMed · Cited by 5,061
Heterologous Protection Against Influenza by Injection of DNA Encoding a Viral Protein
Ulmer, J. B., Donnelly, J. J., Parker, S. E., Rhodes, G. H., Felgner, P. L., Dwarki, V. J., Gromkowski, S. H., Deck, R. R., DeWitt, C. M., Friedman, A., et al. (1993) · Science · doi:10.1126/science.8456302 · Cited by 2,318
Mammalian Ras interacts directly with the serine/threonine kinase raf
Vojtek, A. B., Hollenberg, S. M., & Cooper, J. A. (1993) · Cell · doi:10.1016/0092-8674(93)90307-c · Cited by 1,941
The MAP kinase cascade is essential for diverse signal transduction pathways
Nishida, E., & Gotoh, Y. (1993) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(93)90019-j · Cited by 1,076
Breast Tumor Cell Lines From Pleural Effusions2
Cailleau, R., Young, R., Olivé, M., & Reeves, W. J. (1974) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/53.3.661 · Cited by 1,015
Normal and oncogenic p21ras proteins bind to the amino-terminal regulatory domain of c-Raf-1
Zhang, X.-F., Settleman, J., Kyriakis, J., Takeuchi-Suzuki, E., Elledge, S. J., Marshall, M. S., Bruder, J. T., Rapp, U. R., & Avruch, J. (1993) · Nature · doi:10.1038/364308a0 · Cited by 858
The ras gene family and human carcinogenesis
Bos, J. L. (1988) · Mutation Research/Reviews in Genetic Toxicology · doi:10.1016/0165-1110(88)90004-8 · Cited by 782
Monia, B. P., Lesnik, E. A., Gonzalez, C., Lima, W. F., McGee, D., Guinosso, C. J., Kawasaki, A. M., Cook, P. D., & Freier, S. M. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)85268-7 · Cited by 778
Self-citationIsolation of a transforming sequence from a human bladder carcinoma cell line
Shih, C., & Weinberg, R. A. (1982) · Cell · doi:10.1016/0092-8674(82)90100-3 · Cited by 765
Direct interaction of Ras and the amino-terminal region of Raf-1 in vitro
Warne, P. H., Vician, P. R., & Downward, J. (1993) · Nature · doi:10.1038/364352a0 · Cited by 712
Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.
Bennett, C. F., Chiang, M. Y., Chan, H., Shoemaker, J. E., & Mirabelli, C. K. (1992) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)09229-6 · Cited by 612
The ins and outs of Raf kinases
Daum, G., Eisenmann-Tappe, I., Fries, H.-W., Troppmair, J., & Rapp, U. R. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90133-3 · Cited by 524
Structure and biological activity of v-raf, a unique oncogene transduced by a retrovirus.
Rapp, U. R., Goldsborough, M. D., Mark, G. E., Bonner, T. I., Groffen, J., Reynolds, F. H., & Stephenson, J. R. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.14.4218 · Cited by 483
Chiang, M. Y., Chan, H., Zounes, M. A., Freier, S. M., Lima, W. F., & Bennett, C. F. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)55250-9 · Cited by 463
Diversity in function and regulation of MAP kinase pathways
Blumer, K. J., & Johnson, G. L. (1994) · Trends in Biochemical Sciences · doi:10.1016/0968-0004(94)90147-3 · Cited by 462
Therapeutic Applications of Oligonucleotides
Crooke, S. T. (1992) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.32.040192.001553 · Cited by 446
Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T., & Tokunaga, T. (1992) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1992.tb02102.x · Cited by 366
Critical tyrosine residues regulate the enzymatic and biological activity of Raf-1 kinase.
Fabian, J. R., Daar, I. O., & Morrison, D. K. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.11.7170 · Cited by 353
Stein, C. A. (1995) · Nature Medicine · doi:10.1038/nm1195-1119 · Cited by 255
Selective inhibition of mutant Ha-ras mRNA expression by antisense oligonucleotides.
Monia, B. P., Johnston, J. F., Ecker, D. J., Zounes, M. A., Lima, W. F., & Freier, S. M. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)88650-7 · Cited by 254
Self-citationHoke, G. D., Draper, K., Freier, S. M., Gonzalez, C., Driver, V. B., Zounes, M. C., & Ecker, D. J. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.20.5743 · Cited by 248
Dean, N. M., & McKay, R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.24.11762 · Cited by 242
Mutational activation of c-raf-1 and definition of the minimal transforming sequence.
Heidecker, G., Huleihel, M., Cleveland, J. L., Kolch, W., Beck, T. W., Lloyd, P., Pawson, T., & Rapp, U. R. (1990) · Molecular and Cellular Biology · doi:10.1128/mcb.10.6.2503 · Cited by 240
Inhibition of cellular ras prevents smooth muscle cell proliferation after vascular injury in vivo
Indolfi, C., Avvedimento, E. V., Rapacciuolo, A., Lorenzo, E. D., Esposito, G., Stabile, E., Feliciello, A., Mele, E., Giuliano, P., Condorelli, G., et al. (1995) · Nature Medicine · doi:10.1038/nm0695-541 · Cited by 228
Pharmacokinetic properties of several novel oligonucleotide analogs in mice.
Crooke, S. T., Graham, M. J., Zuckerman, J. E., Brooks, D., Conklin, B. S., Cummins, L. L., Greig, M. J., Guinosso, C. J., Kornbrust, D., Manoharan, M., et al. (1996) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12951-0 · Cited by 227
Implication of RNA structure on antisense oligonucleotide hybridization kinetics
Lima, W. F., Monia, B. P., Ecker, D. J., & Freier, S. M. (1992) · Biochemistry · doi:10.1021/bi00163a013 · Cited by 226
Self-citationA single amino acid change in Raf-1 inhibits Ras binding and alters Raf-1 function.
Fabian, J. R., Vojtek, A. B., Cooper, J. A., & Morrison, D. K. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.13.5982 · Cited by 193
Bennett, C. F., Kornbrust, D., Henry, S., Stecker, K., Howard, R., Cooper, S., Dutson, S., Hall, W., & Jacoby, H. I. (1997) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)36471-7 · Cited by 190
Stepkowski, S. M., Tu, Y., Condon, T. P., & Bennett, C. F. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.11.5336 · Cited by 142
Nucleotide Sequence Analysis of the T24 Human Bladder Carcinoma Oncogene
Reddy, E. P. (1983) · Science · doi:10.1126/science.6844927 · Cited by 129
Oligonucleotide Sequences Required for Natural Killer Cell Activation
Kuramoto, E., Yano, O., Kimura, Y., Baba, M., Makino, T., Yamamoto, S., Yamamoto, T., Kataoka, T., & Tokunaga, T. (1992) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1992.tb02734.x · Cited by 128
Complementary oligonucleotide binding to transfer RNA
Uhlenbeck, O. C. (1972) · Journal of Molecular Biology · doi:10.1016/0022-2836(72)90489-5 · Cited by 128
In vitro pharmacokinetics of phosphorothioate antisense oligonucleotides.
Crooke, R. M., Graham, M. J., Cooke, M. E., & Crooke, S. T. (1995) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12072-7 · Cited by 107
Molecular cloning of an activated human oncogene, homologous to v-raf, from primary stomach cancer.
Shimizu, K., Nakatsu, Y., Sekiguchi, M., Hokamura, K., Tanaka, K. Y., Terada, M., & Sugimura, T. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5641 · Cited by 102
Yamamoto, T., Yamamoto, S., Kataoka, T., & Tokunaga, T. (1994) · Microbiology and Immunology · doi:10.1111/j.1348-0421.1994.tb01867.x · Cited by 98
Activation of Human raf Transforming Genes by Deletion of Normal Amino-Terminal Coding Sequences
Stanton, V. P., & Cooper, G. M. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.3.1171 · Cited by 96
Herschlag, D., & Cech, T. R. (1990) · Biochemistry · doi:10.1021/bi00496a004 · Cited by 94
Bacon, T. A., & Wickstrom, E. (1991) · PubMed · Cited by 92
Four human carcinoma cell lines with novel mutations in position 12 of c-K-ras oncogene
Valenzuela, D., & Groffen, J. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.2.843 · Cited by 86
Fukui, M., Yamamoto, T., Kawai, S., Maruo, K., & Toyoshima, K. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.17.5954 · Cited by 68
Rapp, U. R., Storm, S. M., & Cleveland, J. L. (1987) · Hämatologie und Bluttransfusion · doi:10.1007/978-3-642-72624-8_97 · Cited by 10
Cited by
Targeting RAS signalling pathways in cancer therapy
Downward, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc969 · Cited by 3,256
Regulation of matrix metalloproteinase expression in tumor invasion
Westermarck, J., & Kähäri, V. (1999) · The FASEB Journal · doi:10.1096/fasebj.13.8.781 · Cited by 1,494
Bennett, C. F., & Swayze, E. E. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105654 · Cited by 1,374
Blocking Oncogenic Ras Signaling for Cancer Therapy
Adjei, A. A. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.14.1062 · Cited by 831
Chemistry, structure and function of approved oligonucleotide therapeutics
Egli, M., & Manoharan, M. (2023) · Nucleic Acids Research · doi:10.1093/nar/gkad067 · Cited by 828
Metadata
- Authors
- Monia, B. P., Johnston, J. F., Geiger, T., Muller, M., & Fabbro, D.
- Venue
- Nature Medicine
- Published
- 1996-06
- Volume
- 2
- Issue
- 6
- Pages
- 668-675
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W2030889696
- Cited by
- 447
- References
- 43
- FWCI
- 16.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.